摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(3-Fluorophenyl)-8-(trifluoromethyl)imidazo[1,2-a]pyridin-3-amine

中文名称
——
中文别名
——
英文名称
2-(3-Fluorophenyl)-8-(trifluoromethyl)imidazo[1,2-a]pyridin-3-amine
英文别名
2-(3-fluorophenyl)-8-(trifluoromethyl)imidazo[1,2-a]pyridin-3-amine
2-(3-Fluorophenyl)-8-(trifluoromethyl)imidazo[1,2-a]pyridin-3-amine化学式
CAS
——
化学式
C14H9F4N3
mdl
——
分子量
295.23
InChiKey
XPBSMJCNORUQJS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.1
  • 重原子数:
    21
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.07
  • 拓扑面积:
    43.3
  • 氢给体数:
    1
  • 氢受体数:
    6

文献信息

  • [EN] BICYCLIC HETEROARYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS<br/>[FR] COMPOSÉS D'HÉTÉROARYLE URÉE, THIOURÉE,GUANIDINE ET CYANOGUANIDINE EN TANT QU'INHIBITEURS DE LA KINASE TRKA
    申请人:ARRAY BIOPHARMA INC
    公开号:WO2014078408A1
    公开(公告)日:2014-05-22
    Compounds of Formula I or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.
    式I化合物或其立体异构体、互变异构体或药学上可接受的盐、溶剂合物或前药,其中环A、环C和X如本文所定义,是TrkA激酶的抑制剂,并且在治疗可以用TrkA激酶抑制剂治疗的疾病中具有用处,如疼痛、癌症、炎症/炎症性疾病、神经退行性疾病、某些传染病、干燥综合征、子宫内膜异位症、糖尿病周围神经病变、前列腺炎和盆腔疼痛综合征。
  • BICYCLIC HETEROARYL UREA, THIOUREA, GUANIDINE AND CYANOGUANIDINE COMPOUNDS AS TRKA KINASE INHIBITORS
    申请人:ARRAY BIOPHARMA INC.
    公开号:US20160355517A1
    公开(公告)日:2016-12-08
    Compounds of Formula I or stereoisomers, tautomers, or pharmaceutically acceptable salts, solvates or prodrugs thereof, wherein Ring A, Ring C and X are as defined herein, are inhibitors of TrkA kinase and are useful in the treatment of diseases which can be treated with a TrkA kinase inhibitor such as pain, cancer, inflammation/inflammatory diseases, neurodegenerative diseases, certain infectious diseases, Sjogren's syndrome, endometriosis, diabetic peripheral neuropathy, prostatitis and pelvic pain syndrome.
  • US9822118B2
    申请人:——
    公开号:US9822118B2
    公开(公告)日:2017-11-21
查看更多